'Pharmaceutical Anti-counterfeiting Technologies Market Will Reach $1.2bn in 2015' Predicts Visiongain Report

'Pharmaceutical Anti-counterfeiting Technologies Market Will Reach $1.2bn in 2015' Predicts Visiongain Report PR Newswire LONDON, October 29, 2012 LONDON, October 29, 2012 /PRNewswire/ -- A new report by Visiongain predicts that the world market for pharmaceutical anti-counterfeiting technologies will reach $1.2bn in 2015. That revenue forecast and others appear in Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022. Visiongain is a business information provider based in London, UK. That study predicts that the pharmaceutical anti-counterfeiting market will grow strongly from 2012 to 2022. The illicit trade in counterfeit drugs costs the pharmaceutical industry billions of dollars every year. Also, the consumption of counterfeit drugs poses a serious threat to public health. Visiongain believes drug counterfeiting is one of the most pressing challenges facing the pharmaceutical industry. The more-widespread use of anti-counterfeiting technologies will help to defeat counterfeiting activities. Many opportunities exist for pharma companies and technology suppliers from 2012 to 2022, the report shows. Dr Peter Williamson, a pharmaceutical industry analyst in Visiongain, said: "Growth of the market will be stimulated by the introduction of industry-wide standards. To achieve this, regulatory bodies will enforce mandatory supply chain track- and-trace technologies.